We recently compiled a list of the 10 Best Debt Free Mid Cap Stocks to Buy Now. In this article, we are going to take a look ...

Stifel analyst Benjamin Burnett lowered the firm’s price target on Revolution Medicines (RVMD) to $64 from $78 and keeps a Buy rating on the ...

Revolution Medicines (NASDAQ:RVMD – Free Report) had its price objective cut by Stifel Nicolaus from $78.00 to $64.00 in a research report released on Tuesday,Benzinga reports. They currently have a ...

To listen to a live webcast of any of these events, or access archived webcasts, please visit: https://ir.revmed.com/events-and-presentations. Following the live webcasts, replays will be available on ...

In trading on Tuesday, shares of Revolution Medicines Inc (Symbol: RVMD) entered into oversold territory, hitting an RSI reading of 28.1, after changing hands as low as $33.25 per share.

Revolution Medicines, Inc. REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies ...

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has been assigned a consensus recommendation of “Buy” from the thirteen analysts that are covering the company, Ratings reports. Twelve ...

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...

REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced ...

In this article, we are going to take a look at where Revolution Medicines, Inc. (NASDAQ:RVMD) stands against the other debt free mid cap stocks. Debt-free mid-cap stocks currently offer ...